{"organizations": [], "uuid": "ee19519ae7ff0ffb549827831f38a4eaa7fe8873", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.wsj.com", "main_image": "https://images.wsj.net/im-5370/social", "site_section": "https://www.wsj.com/news/markets", "section_title": "Stock Market &amp; Finance News - Wall Street Journal", "url": "https://www.wsj.com/articles/takeda-shares-fall-as-investors-queasy-over-possible-bid-for-shire-1522311025", "country": "US", "domain_rank": 387, "title": "Takeda Shares Fall as Investors Queasy Over Possible Bid for Shire", "performance_score": 0, "site": "wsj.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-29T12:10:00.000+03:00", "replies_count": 0, "uuid": "ee19519ae7ff0ffb549827831f38a4eaa7fe8873"}, "author": "Megumi Fujikawa", "url": "https://www.wsj.com/articles/takeda-shares-fall-as-investors-queasy-over-possible-bid-for-shire-1522311025", "ord_in_thread": 0, "title": "Takeda Shares Fall as Investors Queasy Over Possible Bid for Shire", "locations": [], "entities": {"persons": [{"name": "takeda", "sentiment": "none"}, {"name": "shire", "sentiment": "none"}], "locations": [{"name": "tokyo", "sentiment": "none"}, {"name": "u.s.", "sentiment": "none"}, {"name": "ireland", "sentiment": "none"}, {"name": "switzerland", "sentiment": "none"}], "organizations": [{"name": "shire", "sentiment": "negative"}, {"name": "takeda pharmaceutical co", "sentiment": "negative"}, {"name": "takeda", "sentiment": "none"}, {"name": "nycomed a/s", "sentiment": "none"}, {"name": "millennium pharmaceuticals inc.", "sentiment": "none"}, {"name": "shire plc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "TOKYO—Takeda Pharmaceutical Co. shares fell 7.4% on Thursday to their lowest level in more than a year, over concerns that the potential of a blockbuster deal to acquire Shire PLC was too much for the Japanese company to swallow.\n\nTakeda said Wednesday it was weighing a bid for Western rival Shire, raising the prospect of a combination that would create a global top-10 drug maker with a market value of more than $80 billion. It called the study “exploratory” and said it would decide by April 25 whether to go through with such...  ", "external_links": ["https://djcs-olympics.s3.amazonaws.com/custom-data-charts/custom-data-chart-wsj-0.8.32.min.js"], "published": "2018-03-29T12:10:00.000+03:00", "crawled": "2018-03-29T15:29:52.021+03:00", "highlightTitle": ""}